To complicate matters further, the growing use of [anti-obesity medications] in children, typically over the age of 12, has caused considerable debate, likely increasing the risks of ocular complications in later life, they suggest
Key Findings Key Market Driver: Increasing diabetes prevalence contributes 62% growth influence, obesity management demand adds 57%
Following the initial rounds of therapy, the frequency of sessions may be reduced, with patients returning for periodic treatments based on their ongoing health needs and goals
The Sanctuary (1908 W Allen St, Suite 104) will be on the right, near the Allentown Farmers Market
Dose escalation speed is perhaps the most significant modifiable factor
Metabolic syndrome update